Can cholinesterase inhibitors provide additional effects to cholinergic neurotransmission enhancement?

Author： López Manuela Arias Esperanza Sobrado Mónica Lorrio Silvia Roda José Garcia Antoni

ISSN： 0895-8696

Source： Journal of Molecular Neuroscience, Vol.30, Iss.1-2, 2006-02, pp. : 141-144

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Sex and Gender Differences in the Brain Cholinergic System and in the Response to Therapy of Alzheimer Disease with Cholinesterase Inhibitors

Current Alzheimer Research, Vol. 15, Iss. 11, 2018-09 ,pp. : 1077-1084

Bentham Science Publishers

Access to resources Recommend Favorite

Brain perfusion effects of cholinesterase inhibitors in Parkinson’s disease with dementia

By Ceravolo R. Volterrani D. Frosini D. Bernardini S. Rossi C. Logi C. Manca G. Kiferle L. Mariani G. Murri L. Bonuccelli U.

Journal of Neural Transmission, Vol. 113, Iss. 11, 2006-11 ,pp. : 1787-1790

Springer Publishing Company

Access to resources Recommend Favorite

Cholinesterase Inhibitors and Beyond

Current Alzheimer Research, Vol. 6, Iss. 2, 2009-01 ,pp. : 86-96

Bentham Science Publishers

Access to resources Recommend Favorite

Cholinergic Neurotransmission Has Different Effects on Cerebral Glucose Consumption and Blood Flow in Young Normals, Aged Normals, and Alzheimer's Disease Patients

By Blin J. Ivanoiu A. Coppens A. de Volder A. Labar D. Michel C. Laterre E.C.

NeuroImage, Vol. 6, Iss. 4, 1997-11 ,pp. : 335-343

Academic Press

Access to resources Recommend Favorite

The Effects of Long-Term Treatment with Metrifonate, a Cholinesterase Inhibitor, on Cholinergic Activity, Amyloid Pathology, and Cognitive Function in APP and PS1 Doubly Transgenic Mice

By Liu L. Ikonen S. Heikkinen T. Tapiola T. van Groen T. Tanila H.

Experimental Neurology, Vol. 173, Iss. 2, 2002-02 ,pp. : 196-204

Elsevier

Access to resources Recommend Favorite